BIOMAT Database Logo BIOMAT Database Logo

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis. 2012

Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB, Groningen, The Netherlands. w.noordzij@gmail.com

OBJECTIVE Cardiac amyloidosis is a rare disorder, but it may lead to potentially life-threatening restrictive cardiomyopathy. Cardiac manifestations frequently occur in primary amyloidosis (AL) and familial amyloidosis (ATTR), but are uncommon in secondary amyloidosis (AA). Echocardiography is the method of choice for assessing cardiac amyloidosis. Amyloid deposits impair the function of sympathetic nerve endings. Disturbance of myocardial sympathetic innervations may play an important role in the remodelling process. (123)I-MIBG can detect these innervation changes. METHODS Patients with biopsy-proven amyloidosis underwent general work-up, echocardiography and (123)I-MIBG scintigraphy. Left ventricular internal dimensions and wall thickness were measured, and highly refractile cardiac echoes (sparkling) were analysed. Early (15 min) and late (4 h) heart-to-mediastinum ratio (HMR) and wash-out rate were determined after administration of MIBG. RESULTS Included in the study were 61 patients (30 women and 31 men; mean age 62 years; 39 AL, 11 AA, 11 ATTR). Echocardiographic parameters were not significantly different between the groups. Sparkling was present in 72 % of ATTR patients, in 54 % of AL patients and in 45 % of AA patients. Mean late HMR in all patients was 2.3 ± 0.75, and the mean wash-out rate was 8.6 ± 14 % (the latter not significantly different between the patient groups). Late HMR was significantly lower in patients with echocardiographic signs of amyloidosis than in patients without (2.0 ± 0.70 versus 2.8 ± 0.58, p < 0.001). Wash-out rates were significantly higher in these patients (-3.3 ± 9.9 % vs. 17 ± 10 %, p < 0.001). In ATTR patients without echocardiographic signs of amyloidosis, HMR was lower than in patients with the other types (2.0 ± 0.59 vs. 2.9 ± 0.50, p = 0.007). CONCLUSIONS MIBG HMR is lower and wash-out rate is higher in patients with echocardiographic signs of amyloidosis. Also, (123)I-MIBG scintigraphy can detect cardiac denervation in ATTR patients before signs of amyloidosis are evident on echocardiography.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009411 Nerve Endings Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS. Ending, Nerve,Endings, Nerve,Nerve Ending
D005260 Female Females
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D013564 Sympathetic Nervous System The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system. Nervous System, Sympathetic,Nervous Systems, Sympathetic,Sympathetic Nervous Systems,System, Sympathetic Nervous,Systems, Sympathetic Nervous

Related Publications

Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging.
August 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.
November 1989, Journal of the American College of Cardiology,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Cardiac sympathetic denervation in amyloidosis.
June 2001, Clinical nuclear medicine,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine.
April 1996, European journal of nuclear medicine,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability.
April 1999, European journal of nuclear medicine,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
June 2010, Journal of the American College of Cardiology,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Changes in cardiac sympathetic nerve activity on 123 I-metaiodobenzylguanidine scintigraphy after MitraClip therapy.
April 2021, ESC heart failure,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia.
May 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
I-123 metaiodobenzylguanidine (MIBG) in sympathetic denervation and reinnervation of salivary glands in a child with cervical neuroblastoma.
March 2008, Clinical nuclear medicine,
Walter Noordzij, and Andor W J M Glaudemans, and Ronald W J van Rheenen, and Bouke P C Hazenberg, and René A Tio, and Rudi A J O Dierckx, and Riemer H J A Slart
Iodine-123-metaiodobenzylguanidine scintigraphy of total cardiac adrenergic denervation in Brugada syndrome.
March 2002, Japanese heart journal,
Copied contents to your clipboard!